BRIEF published on 03/11/2025 at 06:50, 1 year 4 months ago Solid performance and promising outlook for Galenica in 2024 Financial Growth Home Care Digital Innovation Galenica Pharmacies In Switzerland
PRESS RELEASE published on 03/11/2025 at 06:45, 1 year 4 months ago Galenica continues to grow in 2024 Galenica Group reports strong growth in 2024 financial year, with sales up 4.7% to CHF 3,921.1 million. Adjusted EBIT increases by 10.3%. Guidance for 2025 includes sales growth of 3-5% Financial Results Sales Growth 2024 2025 Galenica Group
BRIEF published on 01/23/2025 at 07:05, 1 year 6 months ago Galenica Nominates Nadine Balkanyi-Nordmann for Board of Directors Legal Expertise ESG Compliance Galenica AG Board Nomination Nadine Balkanyi-Nordmann
PRESS RELEASE published on 01/23/2025 at 07:00, 1 year 6 months ago Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors Galenica nominates Nadine Balkanyi-Nordmann, legal and compliance expert, for the Board of Directors. The upcoming AGM aims to strengthen governance and risk management Board Of Directors Compliance AGM Galenica Nadine Balkanyi-Nordmann
BRIEF published on 01/23/2025 at 06:50, 1 year 6 months ago Galenica records solid growth in 2024 EBIT Galenica Growth 2024 Logistics & IT Swiss Pharmacy
PRESS RELEASE published on 01/23/2025 at 06:45, 1 year 6 months ago Galenica reports strong sales growth once again Galenica reports strong sales growth once again in 2024, outperforming pharmaceutical market. Guidance for 2024 annual results confirmed, projecting EBIT growth between 8%-11% Sales Growth EBIT Growth Galenica Pharmaceutical Market 2024 Results
BRIEF published on 10/24/2024 at 06:50, 1 year 9 months ago Galenica Reports Robust Sales Growth in Third Quarter Sales Growth Pharmaceutical Market Galenica AG Generics And Biosimilars Logistics & IT
PRESS RELEASE published on 10/24/2024 at 06:45, 1 year 9 months ago Galenica increases sales growth in the third quarter Galenica reports 4.1% sales growth in the third quarter of 2024, outperforming the pharmaceutical market. Confirms sales growth outlook for 2024 2024 Outlook Sales Growth Galenica Pharmaceutical Market Third Quarter
BRIEF published on 08/06/2024 at 07:05, 2 years ago Expansion of management and handover to the position of CFO at Galenica CFO Reorganization Strategy Galenica Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 2 years ago Expansion of the Executive Committee and handover of the position of CFO Galenica restructures its executive team to enhance customer focus. CFO Felix Burkhard to step down by end of 2024, Julian Fiessinger to take over. Strategic aims include growth and improved customer satisfaction CFO Restructuring Growth Galenica Customer Focus
Published on 08/07/2026 at 00:45, 8 hours 44 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 10 hours 14 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 11 hours 14 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 11 hours 24 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 11 hours 29 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/07/2026 at 09:05, 24 minutes ago ROHM's New 2nd-generation Terahertz Wave Oscillation Device Delivers 4 Times Higher Output Power
Published on 08/07/2026 at 09:05, 24 minutes ago FAMILIARITÉ: A Poetic Convergence of Cinema and Literature
Published on 08/07/2026 at 09:01, 28 minutes ago Original-Research: GFT Technologies SE (von NuWays AG): BUY
Published on 08/07/2026 at 08:30, 59 minutes ago Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/06/2026 at 18:26, 15 hours 3 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 17:45, 15 hours 44 minutes ago Declaration of voting rights at the end of July 2026
Published on 08/06/2026 at 17:35, 15 hours 54 minutes ago Groupe des Assurances du Crédit Mutuel (GACM)’s Solvency II ratio was 227% as of June 30, 2026
